Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 18;78(6):1045-1054.
doi: 10.1016/j.molcel.2020.05.014. Epub 2020 Jun 8.

Cell Death in the Origin and Treatment of Cancer

Affiliations
Free article
Review

Cell Death in the Origin and Treatment of Cancer

Andreas Strasser et al. Mol Cell. .
Free article

Abstract

Cell death, or, more specifically, cell suicide, is a process of fundamental importance to human health. Throughout our lives, over a million cells are produced every second. When organismal growth has stopped, to balance cell division, a similar number of cells must be removed. This is achieved by activation of molecular mechanisms that have evolved so that cells can destroy themselves. The first clues regarding the nature of one of these mechanisms came from studying genes associated with cancer, in particular the gene for BCL-2. Subsequent studies revealed that mutations or other defects that inhibit cell death allow cells to accumulate, prevent removal of cells with damaged DNA, and increase the resistance of malignant cells to chemotherapy. Knowledge of this mechanism has allowed development of drugs that kill cancer cells by directly activating the cell death machinery and by synergizing with conventional chemotherapy as well as targeted agents to achieve improved outcomes for cancer patients.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests D.L.V. and A.S. are employees of The Walter and Eliza Hall Institute. This institute had a collaboration with Genentech and AbbVie to develop BH3-mimetic drugs for cancer therapy and is receiving milestone payments and royalties from the sale of venetoclax. The Walter and Eliza Hall Institute also has an ongoing collaboration with Servier to develop inhibitors of MCL-1 for cancer therapy. A.S. is an advisor and received research funding from Servier.

Publication types

LinkOut - more resources